Skip to content Skip to footer
Subscribe Now
Abbott
NEWS

Abbott’s Navitor TAVI System Receives European CE Mark for Aortic Stenosis in Patients at Low or Intermediate-Risk for Surgery

Shots:Abbott has received the CE Mark approval for Navitor transcatheter aortic valve implantation(TAVI) system to expand its use in people with symptomatic, severe aortic stenosis who are at low or intermediate risk for open-heart surgeryApproval was backed by VANTAGE study of Navitor TAVI, which met its safety & efficacy 1EPs in above ptsTrial showed…
September 1, 2025

Read more

Viewpoints_Michael Dale
VIEWPOINTS

PharmaShots Interview: Abbott’s Michael Dale Shares Insight on the CE Mark for the Next-Generation Navitor TAVI System

In an interview with PharmaShots, Michael Dale, Senior Vice President of the Structural Heart division at Abbott shared his views on the Navitor's approval in the EU for patients with severe aortic stenosis who are at high or extreme surgical risk for open-heart surgery.Shots:Abbott has received CE Mark approval for its latest-generation transcatheter aortic…
September 3, 2021

Read more